Difficult-to-Treat Stenotrophomonas maltophilia Pneumonia: Unrecognized Factors and the Challenges of Interpretation
-
By
-
Xiaoqin Li
-
Lei Zhang
-
Li Peng
-
September 21, 2026
Clinical Scorecard: Difficult-to-Treat Stenotrophomonas maltophilia Pneumonia: Unrecognized Factors and the Challenges of Interpretation
At a Glance
| Category | Detail |
|---|
| Condition | Difficult-to-Treat Stenotrophomonas maltophilia Pneumonia |
| Key Mechanisms | Infection characterized by variable culture sensitivity and challenges in empirical therapy. |
| Target Population | Patients with microbiologically confirmed DTR S. maltophilia pneumonia. |
| Care Setting | ICU |
Key Highlights
- Study highlights issues with case ascertainment and generalizability of findings.
- Emphasis on the limitations of microbiology database searches for respiratory specimens.
- Concerns regarding the representativeness of the patient cohort due to selection effects.
- Questioning the generalizability of reported MIC data and susceptibility testing methods.
- Call for future studies to include culture-negative cases and standardize susceptibility testing.
Guideline-Based Recommendations
Diagnosis
- Focus on microbiologically confirmed cases for accurate diagnosis.
Management
- Consider empirical therapy for suspected cases despite negative cultures.
Monitoring & Follow-up
- Monitor outcomes in patients with confirmed infections and assess differences in culture-negative cases.
Risks
- Be aware of selection bias in reported outcomes and the limitations of culture sensitivity.
Patient & Prescribing Data
Patients with ICU-acquired pneumonia caused by DTR S. maltophilia.
Therapeutic decisions may be influenced by culture results and susceptibility testing.
Clinical Best Practices
- Standardize susceptibility testing methods across centers.
- Limit interpretation of findings to microbiologically confirmed cases.
Related Resources & Content
